Leaflet KANAMICINA PANPHARMA 1g powder for solution for injection / infusion
Indicated for: bacterial infections
Route of administration: injectable / infusion
Substance: kanamycin (aminoglycoside antibiotic)
ATC: J01GB04 (Antiinfectives for systemic use | Aminoglycoside antibacterials | Other aminoglycosides)
Dose adjustment may be needed in kidney disease.
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
Seek medical advice if severe or persistent diarrhea occurs.
This medicine may affect the kidneys.
This medicine may affect hearing or balance.
Use during pregnancy only on medical advice.
Kanamycin is an aminoglycoside antibiotic used to treat severe bacterial infections such as tuberculosis or abdominal infections. It works by inhibiting bacterial protein synthesis, thereby killing susceptible bacteria.
The medication is usually administered via intramuscular or intravenous injection under medical supervision.
Side effects may include kidney function impairment, hearing loss, or allergic reactions. Long-term use requires careful monitoring to prevent toxicity.
Patients should inform their doctor about any other medications they are taking and avoid concurrent use with other ototoxic or nephrotoxic drugs. Pregnant or breastfeeding women should consult a specialist before use.
General data about KANAMICINA PANPHARMA 1g
- Substance: kanamycin
- Date of latest medicines list: 01-03-2022
- Product code: W61665001
- Concentration: 1g
- Pharmaceutical form: powder for solution for injection / infusion
- Quantity: 50
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for kanamycin
Concentrations available for kanamycin
- 1%
- 10mg/g
- 1g